Serological Diagnosis Usefulness in Myasthenia Gravis: Study of a Group of Algerian Patients
Received Date: Jun 02, 2022 / Published Date: Jun 30, 2022
Abstract
Parkinson disease is the neurological condition with the fastest global growth rate and is currently the main cause of disability. Over 6 million people now have Parkinson disease, up from 2 million in 1990. This number is expected to more than double to nearly 12 million by 2040, primarily due to ageing. The load could increase to nearly 17 million as a result of additional factors like longer life expectancy, a decline in smoking rates, and increased industrialization. Parkinson's disease has always been a rare condition. However, a pandemic of Parkinson's disease brought on by demography and the byproducts of industrialization will need for increased advocacy, targeted preparation, and creative strategies.
Keywords: Myasthenia gravis; Radio immune precipitation assay; Enzyme-linked immunnosorbent assay; Cell-based assay; Acetylcholine receptor: Muscle specific kinase.
Citation: Raache R (2022) Serological Diagnosis Usefulness in Myasthenia Gravis: Study of a Group of Algerian Patients. J Neuroinfect Dis 13: 396. Doi: 10.4172/2314-7326.1000396
Copyright: © 2022 Raache R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 695
- [From(publication date): 0-2022 - Apr 19, 2024]
- Breakdown by view type
- HTML page views: 544
- PDF downloads: 151
